FMC Corporation (FMC)
| Market Cap | 1.37B -74.0% |
| Revenue (ttm) | 3.43B -16.6% |
| Net Income | -2.51B |
| EPS | -20.01 |
| Shares Out | 125.23M |
| PE Ratio | n/a |
| Forward PE | 5.91 |
| Dividend | $0.32 (2.93%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | 3,496,285 |
| Open | 10.98 |
| Previous Close | 10.89 |
| Day's Range | 10.68 - 11.15 |
| 52-Week Range | 10.68 - 44.06 |
| Beta | 0.39 |
| Analysts | Hold |
| Price Target | 16.13 (+47.85%) |
| Earnings Date | Jul 29, 2026 |
About FMC
FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia. The company offers crop protection chemicals, including insecticides, herbicides, and fungicides. It also provides biologicals, crop nutrition, and seed treatment products. It markets its products through its sales organization and alliance partners, independent distributors, and sales representatives. The company was founded in 1883 and is headquartered in Philadel... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for FMC stock is "Hold." The 12-month stock price target is $16.13, which is an increase of 47.85% from the latest price.
News
FMC submits regulatory dossier for rimisoxafen to EPA
FMC (FMC) announced it has submitted the regulatory dossier for rimisoxafen to the U.S. Environmental Protection Agency, or EPA, the first regulatory submission globally for this groundbreaking herbic...
FMC Corporation Files First Global Regulatory Submission for Rimisoxafen with United States Environmental Protection Agency
The submission marks an important milestone in FMC's efforts to advance next-generation weed control technologies as resistance pressure intensifies in key row crop markets. PHILADELPHIA, July 8, 2026...
FMC price target lowered to $14 from $15 at BMO Capital
BMO Capital lowered the firm’s price target on FMC (FMC) to $14 from $15 and keeps a Market Perform rating on the shares. The firm cites the company’s $400M equity…
FMC announces $400M investment from Tessenderlo Group
FMC (FMC) and Tessenderlo Group announced that they have entered into a definitive agreement under which Tessenderlo Group will make a strategic minority equity investment in FMC Corporation of approx...
FMC Corporation Reaches Agreement for $400 Million Minority Equity Investment from Tessenderlo Group
Tessenderlo Group's investment reflects its strategy of making cornerstone minority investments in high-quality companies Investment enables FMC to achieve approximately $1 billion debt paydown target...
FMC announces $114M sale-leaseback of Newark, Delaware property
FMC (FMC) has entered into a framework agreement to sell its property in Newark, Delaware for gross proceeds of approximately $114M, subject to a due diligence period and other closing…
FMC Corporation Announces $114 Million Sale-Leaseback of Newark, Delaware Property
Company will continue to operate its global R&D headquarters at the Stine Research Center PHILADELPHIA, June 23, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural science...
FMC Corporation announces date for second quarter 2026 earnings release and webcast conference call
PHILADELPHIA, June 22, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after the stock market close via P...
FMC price target lowered to $14 from $17 at Citi
Citi analyst Patrick Cunningham lowered the firm’s price target on FMC (FMC) to $14 from $17 and keeps a Neutral rating on the shares as part of a Q2 earnings…
FMC Corporation Transcript: Wolfe Research 3rd Annual Materials of the Future Conference 2026
A $200 million licensing deal and asset sales have advanced debt reduction, while new product launches and a shift to direct sales are strengthening market position. Guidance for Q2 and the full year is reaffirmed, with Isoflex and fluindapyr driving near-term growth.
FMC, Corteva announce co-exclusive rimisoxafen supply and license pact
FMC (FMC) and Corteva (CTVA) announced a co-exclusive strategic supply and license agreement that will expand access to FMC’s rimisoxafen technology across North and South America corn and soybean mar...
FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology
Strategic supply and license agreement will accelerate access for North and South American corn and soybean growers PHILADELPHIA and INDIANAPOLIS, June 16, 2026 /PRNewswire/ -- FMC Corporation (NYSE: ...
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Wolfe Research 3rd Annual Materials of the Future Conference
PHILADELPHIA, June 10, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced that Pierre Brondeau, FMC chairman, chief executive officer and president, and Andrew Sandifer, FMC executive vi...
FMC Corporation Transcript: 16th Annual Wells Fargo Industrials & Materials Conference
Management is pursuing a dual-track strategy: operational turnaround and a strategic review, with clarity on potential transactions expected by late July. New active ingredients are set to drive significant sales growth, while aggressive debt reduction and cost restructuring support financial stability.
FMC Corporation CFO Andrew Sandifer to speak at 16th Annual Wells Fargo Industrials & Materials Conference
PHILADELPHIA, May 26, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced that Andrew Sandifer, FMC executive vice president and chief financial officer, will speak at the 16th Annual We...
FMC Corporation Transcript: 21st Annual Global Farm to Market Conference
Management is executing a 2026 strategic plan focused on debt reduction, manufacturing restructuring, and innovation, while also exploring strategic alternatives such as sale or merger, with a decision expected by July. Financial initiatives include asset sales and credit amendments, and the product pipeline is set to shift the portfolio toward growth by 2027.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at BMO Global Farm to Market Chemicals Conference
PHILADELPHIA, May 11, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced that Pierre Brondeau, FMC chairman, chief executive officer and president, and Andrew Sandifer, FMC executive vic...
FMC divesting India commercial business to Crystal Crop Protection for $252M
FMC (FMC) has signed a definitive agreement to sell FMC India Private to Crystal Crop Protection, a crop solutions company in India, for consideration of $252M, subject to customary adjustments…
FMC Corporation Announces Agreement to Divest India Commercial Business to Crystal Crop Protection Limited
PHILADELPHIA, May 7, 2026 /PRNewswire/ -- FMC Corporation (NYSE:FMC), a leading global agricultural sciences company, announced today it has signed a definitive agreement to sell FMC India Private Lim...
FMC price target raised to $16 from $15 at JPMorgan
JPMorgan raised the firm’s price target on FMC (FMC) to $16 from $15 and keeps a Neutral rating on the shares.
FMC price target raised to $17 from $15 at Citi
Citi raised the firm’s price target on FMC (FMC) to $17 from $15 and keeps a Neutral rating on the shares.
FMC Corporation Earnings Call Transcript: Q1 2026
Q1 2026 results exceeded guidance midpoints, driven by strong new active ingredient sales and cost actions, despite lower overall sales and continued price pressure from generics. Debt reduction initiatives and asset sales are progressing, with full-year guidance maintained amid market and geopolitical uncertainties.
FMC Corporation Earnings release: Q1 2026
FMC Corporation released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
FMC Corporation Slides: Q1 2026
FMC Corporation has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
FMC Corporation Quarterly report: Q1 2026
FMC Corporation has published its Q1 2026 quarterly earnings report on April 30, 2026.